The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression
Open accessAbstract
It is known from a variety of experimental systems that the ability of tumor cells to grow locally and metastasize can be affected by the presence of adjacent normal tissues and cells, particularly mesenchymally derived stromal cells such as fibroblasts. However, the comparative influence of such normal cell-tumor cell interactions on tumor behavior has not been thoroughly investigated from the perspective of different stages of tumor progression. To address this question we assessed the influence of normal dermal fibroblasts on the growth of human melanoma cells obtained from different stages of tumor progression. We found that the in vitro growth of most (4 out of 5) melanoma cell lines derived from early-stage radial growth phase or vertical growth phase metastatically incompetent primary lesions is repressed by coculture with normal dermal fibroblasts, suggesting that negative homeostatic growth controls are still operative on melanoma cells from early stages of disease. On the other hand, 9 out of 11 melanoma cell lines derived from advanced metastatically competent vertical growth phase primary lesions, or from distant metastases, were found to be consistently stimulated to grow in the presence of dermal fibroblasts. Evidence was obtained to show that this discriminatory fibroblastic influence is mediated by soluble inhibitory and stimulatory growth factor(s). Taken together, these results indicate that fibroblast-derived signals can have antithetical growth effects on metastatic versus metastatically incompetent tumor subpopulations. This resultant conversion in responsiveness to host tissue environmental factors may confer upon small numbers of metastatically competent cells a growth advantage, allowing them to escape local growth constraints both in the primary tumor site and at distant ectopic tissue sites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Garin‐Chesa, P., Old, L. J., & Rettig, W. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7235 · Cited by 749
The Sequential Analysis of Cancer Development
Farber, E., & Cameron, R. (1980) · Advances in cancer research · doi:10.1016/s0065-230x(08)60658-2 · Cited by 594
Antitumor effects of interferon
Gresser, I., & Tovey, M. G. (1978) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(78)90009-4 · Cited by 339
Stromal-epithelial interactions in adult organs
Cunha, G. R., Bigsby, R. M., Cooke, P. S., & Sugimura, Y. (1985) · Cell Differentiation · doi:10.1016/0045-6039(85)90481-6 · Cited by 309
Swope, V. B., ABDEL‐MALEK, Z. A., Kassem, L. M., & Nordlund, J. J. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12460991 · Cited by 269
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters
Dotto, G. P., Parada, L. F., & Weinberg, R. A. (1985) · Nature · doi:10.1038/318472a0 · Cited by 201
Growth Dominance of the Metastatic Cancer Cell: Cellular and Molecular Aspects
Kerbel, R. S. (1990) · Advances in cancer research · doi:10.1016/s0065-230x(08)60469-8 · Cited by 178
Whicher, J. T., & Evans, S. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.7.1269 · Cited by 175
Rodeck, U., Herlyn, M., Menssen, H. D., Furlanetto, R. W., & Koprowski, H. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400520 · Cited by 143
Cited by
Sorted by citations
Items 101–200 of 217
The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy
Dong, L., Tian, X., Zhao, Y., Tu, H., Wong, A., & Yang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314775 · Cited by 36
Schmidt, C. M., Settle, S. L., Keene, J. L., Westlin, W., Nickols, G. A., & Griggs, D. W. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006719800907 · Cited by 36
Role of gangliosides in tumour progression: A molecular target for cancer therapy?
Fish, R. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90014-6 · Cited by 33
Hoelting, T., Tezelman, S., SIPERSTEIN, A. E., Duh, Q., & Clark, O. H. (1995) · Thyroid · doi:10.1089/thy.1995.5.35 · Cited by 33
Jørgensen, K., Skrede, M. L., Cruciani, V., Mikalsen, S., Slipicevic, A., & Flørenes, V. A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.143 · Cited by 36
Elwakeel, E., Brüggemann, M., Wagih, J., Lityagina, O., Elewa, M. A. F., Han, Y., Frömel, T., Popp, R., Nicolas, A. M., Schreiber, Y., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2116 · Cited by 32
Bond, K., Chiba, T., Wynne, K. J., Vary, C., Sims‐Lucas, S., Coburn, J. M., & Oxburgh, L. H. (2021) · Cancers · doi:10.3390/cancers13235873 · Cited by 38
Noguchi, N., Kawashiri, S., Tanaka, A., Kato, K., & Nakaya, H. (2003) · Oral Oncology · doi:10.1016/s1368-8375(02)00092-1 · Cited by 32
Willhauck, M. J., Mirancea, N., Vosseler, S., Pavesio, A., Boukamp, P., Mueller, M. M., Fusenig, N. E., & Stark, H.-J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl188 · Cited by 33
Woods, K. V., Adler‐Storthz, K., Clayman, G. L., Francis, G. M., & Grimm, E. A. (1998) · PubMed · Cited by 32
The borderline: Basement membranes and the transition from premalignant to malignant neoplasia
Bosman, F. T. (1994) · Microscopy Research and Technique · doi:10.1002/jemt.1070280306 · Cited by 32
Cell membrane-derived nanovesicles as extracellular vesicle-mimetics in wound healing
Li, W., Zhang, H., Chen, L., Huang, C., Jiang, Z., Zhou, H., Zhu, X., Liu, X., Zheng, Z., Yu, Q., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101595 · Cited by 33
Kawada, M., Yoshimoto, Y., Minamiguchi, K., Kumagai, H., Someno, T., Masuda, T., Ishizuka, M., & Ikeda, D. (2004) · PubMed · Cited by 31
Zhou, L., YANG, K. Y., Wickett, R. R., Kadekaro, A. L., & Zhang, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-5293-6 · Cited by 29
Staroselsky, A. N., Radinsky, R., Fidler, I. J., Pathak, S., Chernajovsky, Y., & Frost, P. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510123 · Cited by 30
Kobayashi, H., Man, S., MacDougall, J. R., Graham, C. H., Lü, C., & Kerbel, R. S. (1994) · PubMed Central · Cited by 30
PAGLIA, D., Oran, A. E., Lü, C., Kerbel, R. S., Sauder, D. N., & McKenzie, R. C. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.455 · Cited by 29
Alpaugh, M. L., Lee, M. C., Nguyen, M. T. N., Deato, M. D. E., Dishakjian, L., & Barsky, S. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5056 · Cited by 29
Relationship between stromal cells and tumor spread through air spaces in lung adenocarcinoma
Xie, Q., Chen, D., Liu, Y., Duan, S., Zhang, F., Zhang, Y., Feng, L., Chen, C., & Chen, Y. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12945 · Cited by 28
Loria, R., Laquintana, V., Scalera, S., Fraioli, R., Caprara, V., Falcone, I., Bazzichetto, C., Martile, M. D., Rosanò, L., Bufalo, D. D., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02354-w · Cited by 26
Abdul‐Wahid, A., Cydzik, M., Fischer, N. W., Prodeus, A., Shively, J. E., Martel, A. L., Alminawi, S., Ghorab, Z., Berinstein, N. L., & Gariépy, J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31586 · Cited by 27
Timmer, A., Oosterhuis, J. W., Koops, H. S., Sleijfer, D. T., Szabó, B. G., & Timens, W. (1994) · PubMed Central · Cited by 27
The Pigmentary System and Inflammation
Nordlund, J. J. (1992) · Pigment Cell Research · doi:10.1111/j.1600-0749.1992.tb00563.x · Cited by 27
Aberrations of growth factor control in metastatic follicular thyroid cancerin vitro
Hoelting, T., Zielke, A., SIPERSTEIN, A. E., Clark, O. H., & Duh, Q. Y. (1994) · Clinical & Experimental Metastasis · doi:10.1007/bf01753838 · Cited by 27
Strickland, J. E., Ueda, M., Hennings, H., & Yuspa, S. H. (1992) · PubMed · Cited by 27
Böhm, M., Schulte, U., Funk, J. O., Raghunath, M., Behrmann, I., Kortylewski, M., Heinrich, P. C., Kues, T., Luger, T., & Schwarz, T. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01372.x · Cited by 24
Saiki, I., Murataxd, J., Yoneda, J., Kobayashi, H., & Azuma, I. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560619 · Cited by 26
Fujita, N., Kataoka, S., Naito, M., Heike, Y., Boku, N., Nakajima, M., & TSURUO, T. (1993) · PubMed · Cited by 26
Certa, U., Wilhelm-Seiler, M., Foser, S., Broger, C., & Neeb, M. (2003) · Gene · doi:10.1016/s0378-1119(03)00722-4 · Cited by 26
Reduction of TGF‐beta activity abrogates growth promoting tumor cell‐cell interactions in vivo
Theodorescu, D., Caltabiano, M. M., GREIG, R. G., Rieman, D. J., & Kerbel, R. S. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041480308 · Cited by 26
Epithelial–Mesenchymal Transition in Development and Diseases
Wu, Y., & Zhou, B. P. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_9 · Cited by 25
Delinassios, J. G., Angeli, F., Koumakis, G., Kumar, S., Kang, W.-H., Sica, G., Iacopino, F., Lama, G., Lamprecht, S. A., Sigal-Batikoff, I., et al. (2015) · PubMed · Cited by 24
Extracellular matrix in invasion and metastasis of oral squamous cell carcinoma
Kumar, K., & Hema, K. (2019) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_97_19 · Cited by 25
Bellei, B., Migliano, E., & Picardo, M. (2020) · Cancers · doi:10.3390/cancers12113400 · Cited by 25
Saleh, N. A., Rode, M. P., Sierra, J. A., Silva, A. H., Miyake, J. A., Filippin-Monteiro, F. B., & Creczynski‐Pasa, T. B. (2020) · Cytotechnology · doi:10.1007/s10616-020-00440-5 · Cited by 26
Surman, M., Kędracka–Krok, S., Hoja-Łukowicz, D., Jankowska, U., Drożdż, A., Stępień, E. Ł., & Przybyło, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082934 · Cited by 24
Alqathama, A. A., Gibbons, S., & Prieto, J. M. (2017) · Oncotarget · doi:10.18632/oncotarget.21625 · Cited by 24
Systems-Level Modeling of Cancer-Fibroblast Interaction
Wadlow, R. C., Wittner, B. S., Finley, S. A., Bergquist, H., Upadhyay, R., Finn, S. P., Loda, M. F., Mahmood, U., & Ramaswamy, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006888 · Cited by 23
Tumor cell motility and metastasis
Silletti, S., Paku, S., & Raz, A. (1997) · Pathology & Oncology Research · doi:10.1007/bf02899927 · Cited by 22
Spontaneous and induced differentiation of human melanoma cells
Valyi-Nagy, I. T., Shih, I., Györfi, T., Greenstein, D., Juhász, I., Herlyn, M., & Elder, D. E. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540125 · Cited by 23
Site-Specific Epithelial-Mesenchymal Interactions in Digestive Neuroendocrine Tumors
Dumortier, J., Ratineau, C., Scoazec, J., Pourreyron, C., Anderson, W., Jacquier, M., Blanc, M., Bernard, C., Bellaton, C., Remy, L., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64771-2 · Cited by 22
Paracrine/autocrine growth mechanisms in tumor metastasis.
Gl, N. (1992) · PubMed · Cited by 22
Targeting the stromal fibroblasts: a novel approach to melanoma therapy
Smalley, K. S. M., Lioni, M., & Herlyn, M. (2005) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.5.6.1069 · Cited by 21
Efimova, E. V., Martinez, O., Lokshin, A. E., Arima, T., & Prabhakar, B. S. (2003) · PubMed · Cited by 19
Interleukin-1 Production in Tumor Cells of Human Melanoma Surgical Specimens
Tyler, D. S., Francis, G. M., Frederick, M. J., Tran, A., ORDÓÑZ, N. G., Smith, J. L., Eton, O. E., Ross, M. I., & Grimm, E. A. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.331 · Cited by 19
Growth Regulation in Normal and Malignant Melanocytes
Halaban, R. (1993) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-84881-0_10 · Cited by 19
Lin, W., Pretlow, T. P., Pretlow, T. G., & Culp, L. A. (1992) · PubMed Central · Cited by 19
Schor, S. L. (1995) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9070-0_14 · Cited by 18
Wang, M., Wu, C., Pan, J.-Y., Zheng, W.-W., Cao, X., & Fan, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117405 · Cited by 17
Analysis of a mathematical model of periodically pulsed chemotherapy treatment
Samanta, G. P., Aíza, R. G., & Sharma, S. (2015) · International Journal of Dynamics and Control · doi:10.1007/s40435-015-0204-z · Cited by 16
IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells
Jen, E. Y., Poindexter, N. J., Farnsworth, E., & Grimm, E. A. (2011) · Melanoma Research · doi:10.1097/cmr.0b013e32834d2506 · Cited by 16
Myoepithelial-Specific CD44 Shedding Is Mediated by a Putative Chymotrypsin-like Sheddase
Lee, M. C., Alpaugh, M. L., Nguyen, M. T. N., Deato, M. D. E., Dishakjian, L., & Barsky, S. H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3918 · Cited by 16
Generation of 3D melanoma models using an assembloid-based approach
Rodrigues, D. B., Moreira, H. R., Jarnalo, M., Horta, R., Marques, A. P., Reis, R. L., & Pirraco, R. P. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.02.023 · Cited by 14
Luciani, M. G., Seok, J., Sayeed, A., Champion, S., Goodson, W. H., Jeffrey, S. S., Xiao, W., Mindrinos, M. N., Davis, R. W., & Dairkee, S. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020016 · Cited by 14
Schor, S. L., Grey, A. M., Ellis, I., Schor, A. M., Howell, A., Sloan, P., & Murphy, R. (1994) · Cancer treatment and research · doi:10.1007/978-1-4615-2592-9_15 · Cited by 14
Zheng, J., & Vaheri, A. I. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610512 · Cited by 14
Rønnov‐Jessen, L. (1996) · The Breast Journal · doi:10.1111/j.1524-4741.1996.tb00117.x · Cited by 14
Liu, R., Cao, K., Tang, Y., Liu, J., Li, J., Chen, J., Wang, S., Chen, Z., & Zhou, J. (2020) · PubMed Central · Cited by 13
Palethorpe, H. M., Leach, D. A., Need, E. F., Drew, P. A., & Smith, E. (2018) · Oncotarget · doi:10.18632/oncotarget.24913 · Cited by 12
Wolfrom, C. M., Raynaud, N., Maigné, J., Papathanassiou, S., Conti, M., Kadhom, N., Hecquet, B., Lévi, F., Gautier, M., & Deschatrette, J. (1994) · Cell Biology and Toxicology · doi:10.1007/bf00756764 · Cited by 12
Ratineau, C., Plateroti, M., Dumortier, J., Blanc, M., Kédinger, M., Chayvialle, J. A., & Roche, C. (1997) · Differentiation · doi:10.1046/j.1432-0436.1997.6230139.x · Cited by 12
The Role of Angiogenesis in Tumor Progression and Metastasis
Rak, J. W., Hegmann, E. J., & Kerbel, R. S. (1993) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(08)60241-6 · Cited by 12
Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer
Okuyama, T., Sameshima, S., Takeshita, E., Mitsui, T., Noro, T., Ono, Y., Noie, T., Ban, S., & Oya, M. (2020) · BMC Cancer · doi:10.1186/s12885-020-07335-w · Cited by 11
Surman, M., Jankowska, U., Wilczak, M., & Przybyło, M. (2023) · Cancers · doi:10.3390/cancers15041097 · Cited by 10
Avagliano, A., & Arcucci, A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220620124138 · Cited by 10
Nesbit, M., Schaider, H., Berking, C., Shih, D.-T., Hsu, M., McBrian, M., Crombleholme, T. M., Elenitsas, R., Buck, C. A., & Herlyn, M. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780340 · Cited by 10
Borchers, A. H., Sanders, L. A., Powell, M. B., & Bowden, G. T. (1997) · Experimental Cell Research · doi:10.1006/excr.1996.3449 · Cited by 10
The metastatic phenotype—prognostic implications
Lindblom, A., & Linder, S. T. (1996) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(96)00213-2 · Cited by 10
Ulmer, A., Körber, V., Schmid, H., & Fierlbeck, G. (1998) · Experimental Dermatology · doi:10.1111/j.1600-0625.1998.tb00297.x · Cited by 10
Hormonal and Stromal Regulation of Normal and Neoplastic Prostatic Growth
Ricke, W. A., Wang, Y. Z., Kurita, T., Hayward, S. W., & Cunha, G. R. (2005) · Springer eBooks · doi:10.1007/3-540-27671-8_8 · Cited by 10
Discovery of Endothelium and Mesenchymal Properties of Primo Vessels in the Mesentery
An, P., Zhendong, S., Jingxing, D., Yaling, L., Bae, K.-H., Shiyun, T., Hesheng, L., Soh, K., Ryu, Y. H., & Kim, S. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/205951 · Cited by 8
Zhou, H., Lü, N., Chen, Z., Song, Q., Yu, H., & Li, X. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00348.x · Cited by 8
Alileche, A. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00359-6 · Cited by 8
The pathogenesis of cancer metastasis: relevance to therapy
Kim, S.-J., Baker, C. H., Kitadai, Y., Nakamura, T., Kuwai, T., Sasaki, T., Langley, R. R., & Fidler, I. J. (2009) · Springer eBooks · doi:10.1007/978-90-481-2289-9_2 · Cited by 9
Tissue Models to Study Tumor-Stroma Interactions
Fusenig, N. E., Skobe, M., Vosseler, S., Hansen, M., Lederle, W., Airola, K., Tomakidi, P., Stark, H.-J., Steinbauer, H., Mirancea, N., et al. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-2008-2_11 · Cited by 8
Surman, M., Wilczak, M., Bzowska, M., Tylko, G., & Przybyło, M. (2024) · Cells · doi:10.3390/cells13161336 · Cited by 7
Géry, B., Coppey, J., & Little, J. B. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02175-2 · Cited by 7
Linck-Paulus, L., Lämmerhirt, L., Völler, D., Meyer, K., Engelmann, J. C., Spang, R., Eichner, N., Meister, G., Kuphal, S., & Bosserhoff, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112259 · Cited by 6
Classical and Quantum Information Processing in DNA-Protein Coding
Koruga, D. L. (2011) · Springer eBooks · doi:10.1007/978-3-642-21913-9_2 · Cited by 5
Yuan, Y. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 5
Fibonacci Nanostructures for Novel Nanotherapeutical Approach
Matija, L., Munćan, J. S., Stanković, I., & Koruga, D. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52727-9.00004-2 · Cited by 5
The Pathogenesis of Cancer Metastasis: Relevance to Biotherapy
Radinsky, R., Aukerman, S. L., & Fidler, I. J. (1998) · Springer eBooks · doi:10.1007/978-94-009-0029-5_2 · Cited by 5
Bantel‐Schaal, U. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00270-0 · Cited by 5
Koruga, Đ. (2005) · Archive of oncology · doi:10.2298/aoo0504115k · Cited by 4
Dielectric response of human melanoma cells on the surface of polymeric chemoattractants
Beard, R. B., Kim, H. J., Roh, H., Moon, K. W., & Chun, H. J. (2012) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-012-0024-6 · Cited by 4
The Role of Endothelin 3 in Melanoma Progression and Metastasis
Chin, N. L. (2015) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc000185 · Cited by 3
Naves, L. B., Almeida, L., & Ramakrishna, S. (2017) · EMJ Oncology · doi:10.33590/emjoncol/10314408 · Cited by 3
Schor, A. M., & Schor, S. L. (2011) · Springer eBooks · doi:10.1007/978-94-007-0659-0_11 · Cited by 3
Matrix metalloproteinases and their inhibitors in tumor invasion and metastasis
Rao, V. H., Singh, R. K., Finnell, R. H., Davé, B. J., Beuhler, B. A., Sanger, W. G., & Schaefer, G. B. (1999) · Journal of Chemical Sciences · doi:10.1007/bf02869913 · Cited by 3
Olaso, E., Arteta, B., Salado, C., Eguilegor, E., Gallot, N., Lopategi, A., Gutierrez, V., Solaun, M., Mendoza, L., & Vidal‐Vanaclocha, F. (2007) · Springer eBooks · doi:10.1007/0-387-33650-8_10 · Cited by 3
Obara, K., Ide, F., Mishima, K., Inoue, H., Yamada, H., Hayashi, Y., & Saito, I. (2006) · Pathobiology · doi:10.1159/000098212 · Cited by 2
Cruz‐Muñoz, W., Francia, G., & Kerbel, R. S. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976117.052 · Cited by 2
Kashchak, N., Tsaryk, R., & Stoika, R. S. (2005) · Cell Biology International · doi:10.1016/j.cellbi.2004.11.009 · Cited by 2
Tissue Models to Study Tumor-Stroma Interactions
Fusenig, N. E., Skobe, M., Vosseler, S., Hansen, M., Lederle, W., Airola, K., Tomakidi, P., Stark, H.-J., Steinbauer, H., Mirancea, N., et al. (2002) · Springer eBooks · doi:10.1007/978-0-306-48362-2_11 · Cited by 2
Nicolson, G. L. (1994) · Springer eBooks · doi:10.1007/978-3-662-03011-0_7 · Cited by 2
Cancer Associated Fibroblasts as Therapeutic Targets
Rupp, C., Dolznig, H., Haslinger, C., Schweifer, N., & Garin‐Chesa, P. (2011) · Springer eBooks · doi:10.1007/978-94-007-0659-0_20 · Cited by 1
Effect of indoleamine 2,3‐dioxygenase expressed by foetal fibroblasts on melanoma cells
Frénard, C., Knol, A., Moigne, M. L., Khammari, A., & Dréno, B. (2016) · Experimental Dermatology · doi:10.1111/exd.13058 · Cited by 1
Nanovesicles for the delivery of siRNA
Sanni, S. E., Favour, I., & Adeyanju, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00010-9 · Cited by 1
Ohfuji, S. (2017) · Comparative Clinical Pathology · doi:10.1007/s00580-017-2557-5 · Cited by 1
Tumor Cell Interactions in Cancer Growth and Expression of the Malignant Phenotype
Miller, F. R., & Miller, B. E. (1993) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(08)60239-8 · Cited by 1
Metadata
- Authors
- Cornil, I., Theodorescu, D., Man, S., Herlyn, M., Jambrosic, J., & Kerbel, R. S.
- Affiliations
- Mount Sinai Hospital (CA)
- ORCID
- Theodorescu, D
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1991-07-15
- Volume
- 88
- Issue
- 14
- Pages
- 6028-6032
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC52015
- OpenAlex
- W2015028428
- Cited by
- 217
- References
- 28
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 6 · 2021: 3 · 2020: 9 · 2019: 4 · 2018: 7 · 2017: 7 · 2016: 7 · 2015: 8 · 2014: 2 · 2013: 5 · 2012: 5
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health (5r01ca044877-08)
- U.S. Public Health Service (R0I-42331)
- National Cancer Institute (CA-25874, P01CA025874, CA 44877)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- melanoma, dermal fibroblasts, tumor microenvironment, tumor progression, tumor growth, metastasis, radial growth phase, vertical growth phase, tumor stroma, soluble growth factors, metastatic competence
- MeSH terms
- Adipose Tissue, Animals, Cattle, Cell Communication, Cell Division, Cells, Cultured, DNA Replication, Endothelium, Vascular, Fibroblasts, Humans, Infant, Newborn, Male, Melanoma, Skin, Skin Physiological Phenomena
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review